Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828126 · ClinicalTrials.gov registry record
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 38
- Enrollment target
NCT00828126: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00828126 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00828126 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn how often using a positron emission tomography-computed tomography (PET-CT) scan in addition to a standard computed tomography (CT) scan will change the surgical plan in patients with metastatic melanoma.
Interventions
- PROCEDURE PET-CT Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-03 |
What the finished NCT00828126 record still lists
NCT00828126 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PET-CT Scan is the first listed.
NCT00828126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00828126 about?
NCT00828126 is a clinical study titled "PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma". The goal of this clinical research study is to learn how often using a positron emission tomography-computed tomography (PET-CT) scan in addition to a standard computed tomography (CT) scan will change the surgical plan in patients with metastatic melanoma.
What is the current status of trial NCT00828126?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2009-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00828126?
The interventions under investigation include: PET-CT Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00828126?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia